Imagine The End of Viruses as We Know Them Today

Our mission is to prove Maxwell's patented "peptoid" virucidal drug class is safe in humans. This world-first drug class that irreversibly inactivates humanity's top threat - highly infectious pandemic viruses. Maxwell's novel and patented anti-infectives have been shown by multiple independent labs (including Stanford, NYU and others) to be rapid killers of the world's deadliest and most contagious pathogens. These preclinical lab tests show these potentially life-saving drugs appear safe in cultured human cells, and are effective at low doses. The irreversible nature of the treatment paired with our preclinical data showing safety in human tissues make it a potential game changing therapeutic.

A big idea, for a big problem. You can help by telling others, especially those who want to help by investing or working with us. We're looking for virologist research doctors, investors, and people who deeply care about averting the next viral pandemic.
 

A Treatment for Viral Infections is Possible

Maxwell's disruptive new, patented drug class is a functional mimic of the peptide used by all human white blood cells to attack viruses - Human Cathelicidin Antimicrobial Peptide known as LL-37. For over 500 million years, LL-37 has successfully defended mammals against viruses without allowing viruses to develop significant resistance. Mimicking LL-37, our peptoids irreversibly entangle the nucleic acids of the virus inactivating the virus's ability to multiply - the biological equivalent of injecting a sticky glue into the internal gears of a complex machine.

Peptoid Biomimetics Explained - A Novel Mechanism

Biomimicry is a proven approach to innovation in therapeutic drug development that simply mimics the natural functions of a healthy body. At Maxwell, we have invented and patented functional mimics of the human body's natural immune peptides, with added strength, allowing our peptoids to fight super bugs longer and harder than any known natural peptide.

Antimicrobial Peptoid

Learn more about Maxwell's peptoid drug class, set to potentially change the way we treat infections.